Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2019-03-22 Audit Report / Informat…
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
公告本公司獨立董事對審計委員會決議事項表示保留意見
Audit Report / Information Classification · 90% confidence The document is a regulatory announcement from a company (國光生) disclosing that an independent director has expressed reservation opinions regarding the audit committee's resolutions. It specifically mentions the 107年度 (2018 fiscal year) financial statements and internal control effectiveness assessment. The document is short (1458 characters) and primarily reports on dissenting opinions about the audit committee's decisions rather than presenting the full audit report or financial statements. It does not contain actual financial data or detailed audit results but is a formal disclosure of opinions and voting outcomes related to audit matters. Therefore, it fits best as an Audit Report / Information (AR) type, which covers standalone audit reports, applied accounting principles, and related committee decisions, excluding full annual reports. The document is not an Annual Report (10-K) or a full Audit Report but an announcement of audit committee opinions and reservations, which aligns with AR. Confidence is high due to the clear focus on audit committee resolutions and independent director opinions on audit matters.
2019-03-22 Chinese
公告本公司獨立董事對審計委員會決議事項表示反對意見
Board/Management Information Classification · 95% confidence The document is a public announcement from a listed company (國光生) regarding the independent directors' dissenting opinions on resolutions made by the audit committee. It details the dates, the dissenting directors, the specific issues they opposed (investigations into inventory valuation and management expenses for certain fiscal years), and the voting results. The content is about board committee decisions and internal governance matters rather than a full audit report or financial statement. It is not a full audit report (AR) because it does not contain audit findings or applied accounting principles, but rather a statement of disagreement on audit committee resolutions. It is also not a management change announcement, earnings release, or other categories. This fits best under Board/Management Information (MANG) as it relates to board committee decisions and director opinions.
2019-03-22 Chinese
公告更正本公司107年現金增資認股基準日
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a listed company (國光生) regarding a correction to the cash capital increase subscription base date for the fiscal year 107 (Taiwan calendar year, corresponding to 2018). It details the number of shares issued, pricing, subscription rights, and related procedural dates. The content focuses on the specifics of a capital increase event, including issuance details, subscription rights, and timing. There is no financial statement or comprehensive financial report included, nor is it a brief announcement of a report publication. The document is clearly an update on a capital raising activity, specifically a cash capital increase. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short (2104 characters), consistent with an announcement rather than a full report. Confidence is high due to the detailed capital increase information and absence of other report types.
2019-03-20 Chinese
更正本公司107年現金增資認股基準日公告相關事宜
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a cash capital increase (現金增資) by the company 國光生. It includes specifics such as the number of shares to be issued, pricing, subscription rights, dates for subscription and payment, and other procedural details. The content focuses on the terms and conditions of the capital increase, including board resolutions and regulatory approvals. There are no financial statements or comprehensive financial performance data included. The document is not a full financial report but an update on financing activity. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2071 characters, which is consistent with an announcement rather than a full report.
2019-03-13 Chinese
公告本公司107年現金增資認股基準日
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a listed company (國光生) regarding a cash capital increase subscription base date and related details. It includes specifics such as the number of shares to be issued, pricing, subscription ratios, dates for subscription and payment, and other procedural information. The content focuses on the company's financing activity, specifically a cash capital increase, which is a form of capital raising. The document length is 2065 characters, which is relatively short and primarily an announcement rather than a detailed financial report. There is no indication of full financial statements or comprehensive financial analysis. Therefore, this document fits best under the category of Capital/Financing Update (CAP).
2019-03-13 Chinese
108年2月營業收入
Regulatory Filings Classification · 90% confidence The document is a summarized revenue report for a company named 國光生 for the period of February 2019 (民國108年02月). It contains monthly and cumulative net operating revenue figures with percentage changes and explanations for revenue changes. The document is short (788 characters) and appears to be a periodic financial summary rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It also does not fit other categories like earnings release or investor presentation. Given the nature of the data and the short length, this is best classified as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements and financial summaries that do not fit other specific categories.
2019-03-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.